BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Longhorn Vaccines and Diagnostics Partners with Promega to Combine Complementary Offerings for Enhanced Sample Collection, Transport and Analysis

  July 29, 2025

   · 

  4 min read
• Press Releases

  Lantern Pharma Announces Appointment of Dr. Lee Schalop to Board of Directors

  July 29, 2025

   · 

  5 min read
• Press Releases

  Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

  July 29, 2025

   · 

  5 min read
• Press Releases

  New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

  July 29, 2025

   · 

  4 min read
• Press Releases

  Aclaris Therapeutics Announces Leadership Transition

  July 29, 2025

   · 

  5 min read
• Press Releases

  Enlivex Reaffirms August 18, 2025 As Target Date For Announcement of Phase II Topline Data

  July 29, 2025

   · 

  5 min read
• Press Releases

  FibroBiologics Files Patent for Methods of Generating Multipotent Cells from Donor Tissue for Clinical Applications

  July 29, 2025

   · 

  4 min read
• Press Releases

  Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments in the Deramiocel Program for the Treatment of Duchenne Muscular Dystrophy

  July 29, 2025

   · 

  4 min read
• Press Releases

  AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

  July 29, 2025

   · 

  6 min read
• Press Releases

  XellSmart Completed World’s First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury

  July 29, 2025

   · 

  5 min read